DK0827751T3 - Medicinsk præparat indeholdende vævsplasminogenaktivator og nicotinamid - Google Patents
Medicinsk præparat indeholdende vævsplasminogenaktivator og nicotinamidInfo
- Publication number
- DK0827751T3 DK0827751T3 DK97115466T DK97115466T DK0827751T3 DK 0827751 T3 DK0827751 T3 DK 0827751T3 DK 97115466 T DK97115466 T DK 97115466T DK 97115466 T DK97115466 T DK 97115466T DK 0827751 T3 DK0827751 T3 DK 0827751T3
- Authority
- DK
- Denmark
- Prior art keywords
- nicotinamide
- plasminogen activator
- preparation containing
- tissue plasminogen
- containing tissue
- Prior art date
Links
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 title 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 title 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 title 1
- 229960003966 nicotinamide Drugs 0.000 title 1
- 235000005152 nicotinamide Nutrition 0.000 title 1
- 239000011570 nicotinamide Substances 0.000 title 1
- 229960000187 tissue plasminogen activator Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25775296 | 1996-09-06 | ||
| JP12808397 | 1997-04-30 | ||
| JP12808497 | 1997-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0827751T3 true DK0827751T3 (da) | 2003-03-31 |
Family
ID=27315682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97115466T DK0827751T3 (da) | 1996-09-06 | 1997-09-05 | Medicinsk præparat indeholdende vævsplasminogenaktivator og nicotinamid |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US6139838A (da) |
| EP (1) | EP0827751B1 (da) |
| DE (1) | DE69719265T2 (da) |
| DK (1) | DK0827751T3 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002210749B2 (en) | 2000-10-31 | 2006-12-21 | Pharma Mar, S.A. | Kahalalide F formulation |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5470419A (en) * | 1977-11-16 | 1979-06-06 | Wakamoto Pharma Co Ltd | Stable urokinase powdery preparaton |
| EP0112940B1 (en) * | 1982-12-30 | 1986-10-15 | Kowa Company, Ltd. | Method of producing a tissue plasminogen activator and composition comprising same |
| EP0156169B1 (en) * | 1984-02-29 | 1991-12-18 | Asahi Kasei Kogyo Kabushiki Kaisha | An aqueous solution of a tissue plasminogen activator dissolved therein at an increased concentration and a method |
| GB8508717D0 (en) * | 1985-04-03 | 1985-05-09 | Beecham Group Plc | Composition |
| IE58574B1 (en) * | 1985-04-22 | 1993-10-06 | Genentech Inc | Human tissue plasminogen activator mutants, methods and intermediates therefor, and compositions using such mutants |
| US4929444A (en) * | 1985-05-28 | 1990-05-29 | Burroughs Wellcome Co. | Low pH pharmaceutical formulation containing t-PA |
| AU569429B2 (en) * | 1985-05-28 | 1988-01-28 | Wellcome Foundation Limited, The | Aqueous acidic tissue plasminogen activator parenternal formulation |
| JPH0672105B2 (ja) * | 1985-10-02 | 1994-09-14 | 持田製薬株式会社 | 血栓溶解剤及びその製法 |
| CA1341444C (en) * | 1986-01-24 | 2003-10-21 | Margaret Y. Insley | Modified tissue plasminogen activator |
| JP2527454B2 (ja) * | 1986-01-31 | 1996-08-21 | ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド | 新しい血栓溶解タンパク質 |
| US5589361A (en) * | 1986-03-18 | 1996-12-31 | Genentech, Inc. | Human tissue-type plasminogen activator variant |
| JPS6338327A (ja) * | 1986-08-04 | 1988-02-18 | Matsushita Electric Ind Co Ltd | 加減算計数回路 |
| US4935237A (en) * | 1988-03-21 | 1990-06-19 | Genentech, Inc. | Processes for the preparation of t-PA mutants |
| EP0365597B2 (en) * | 1987-06-30 | 2005-02-09 | Genentech, Inc. | Improved processes for the treatment of vascular disease |
| JP2708749B2 (ja) * | 1987-08-10 | 1998-02-04 | エーザイ株式会社 | 修飾型tPA含有注射用組成物 |
| IL88247A0 (en) * | 1987-11-06 | 1989-06-30 | Genentech Inc | Novel human tissue-type plasminogen activator variant |
| US4898826A (en) * | 1987-12-10 | 1990-02-06 | Invitron Corporation | Method to solubilize tissue plasminogen activator |
| JP2504102B2 (ja) | 1988-02-17 | 1996-06-05 | 日本電気株式会社 | 逆三角関数演算装置 |
| JPH01221325A (ja) * | 1988-03-01 | 1989-09-04 | Wakamoto Pharmaceut Co Ltd | 組織プラスミノーゲン活性化因子の安定化方法 |
| US5037646A (en) * | 1988-04-29 | 1991-08-06 | Genentech, Inc. | Processes for the treatment of vascular disease |
| JPH0329390A (ja) * | 1989-06-26 | 1991-02-07 | Hitachi Aic Inc | プリント配線板の製造方法 |
| JP2578506B2 (ja) * | 1989-08-10 | 1997-02-05 | 住友重機械工業株式会社 | 射出成形機保圧工程の制御装置及び制御方法 |
| US5242688A (en) * | 1990-12-24 | 1993-09-07 | Eli Lilly And Company | Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants |
| JPH0527607A (ja) * | 1991-07-19 | 1993-02-05 | Canon Inc | 画像形成装置の転写材給送定着装置 |
| JP2971680B2 (ja) * | 1991-10-02 | 1999-11-08 | 山之内製薬株式会社 | 組織プラスミノーゲン活性化因子含有組成物 |
| JPH0672105A (ja) * | 1992-08-25 | 1994-03-15 | Bridgestone Corp | 建設車両用空気入りタイヤ |
| JPH0699324A (ja) * | 1992-09-21 | 1994-04-12 | Power Reactor & Nuclear Fuel Dev Corp | マニプレータ爪先用機能別回転式工具 |
| GB9418092D0 (en) * | 1994-09-08 | 1994-10-26 | Red Cross Found Cent Lab Blood | Organic compounds |
-
1997
- 1997-09-05 DK DK97115466T patent/DK0827751T3/da active
- 1997-09-05 US US08/923,999 patent/US6139838A/en not_active Expired - Fee Related
- 1997-09-05 EP EP97115466A patent/EP0827751B1/en not_active Expired - Lifetime
- 1997-09-05 DE DE69719265T patent/DE69719265T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69719265T2 (de) | 2003-12-04 |
| DE69719265D1 (de) | 2003-04-03 |
| US6139838A (en) | 2000-10-31 |
| EP0827751A2 (en) | 1998-03-11 |
| EP0827751A3 (en) | 1999-02-03 |
| EP0827751B1 (en) | 2003-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO953991D0 (no) | Ultrasomisk og elektro-kirurgisk håndstykke av piezotype | |
| DK0865778T3 (da) | Hygiejniske og medicinske produkter | |
| DE69432971D1 (de) | Trokar und kanüle | |
| DE69611813D1 (de) | Trokar und Kanüle | |
| HUP0002657A3 (en) | Clinical and/or surgical training apparatus | |
| DK0621042T3 (da) | Kirurgisk forbinding og adhæsivsammensætning dertil | |
| NO993868D0 (no) | 3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike | |
| ZA9711364B (en) | Self-blunting needle medical devices and methods of manufacture thereof | |
| NO20001267L (no) | Ekspanderbart kateter for veneombinding og fremgangsmÕte for bruk | |
| GB2277826B (en) | Surgical and/or clinical apparatus | |
| NO975439D0 (no) | Ketonderivater og medisinsk anvendelse derav | |
| PL312718A1 (en) | Competitors and opponents of human interleukine-10 | |
| GB9412711D0 (en) | Medical use of bromelain | |
| DK233787D0 (da) | Fremgangsmaade til oprensning af enkeltkaedet og dobbeltkaedet vaevsplasminogenaktivator | |
| NO20012738D0 (no) | Terapeutiske produkter og anvendelse derav | |
| NO955258D0 (no) | Medisinsk anvendelse av enzymer | |
| NO973980D0 (no) | Imiadazolderivater og medisinsk preparat | |
| NO933021D0 (no) | Sonde for mikroboelgeapparat til klinisk og kirurgisk behandling | |
| AU3501700A (en) | Human endokine alpha and methods of use | |
| DK0827751T3 (da) | Medicinsk præparat indeholdende vævsplasminogenaktivator og nicotinamid | |
| NO20000184D0 (no) | Nye purinderivater og medisinsk anvendelse derav | |
| FI963263A0 (fi) | Bromelaiinin lääkinnällinen käyttö | |
| NO953003D0 (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
| NO985572L (no) | Substituerte amidinobenzenderivater og medisinske preparater derav | |
| NO892506D0 (no) | Kloning og ekspresjon av human vevsfaktor. |